These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 21654361)

  • 21. Whole mounted radical prostatectomy specimens do not increase detection of adverse pathological features.
    Hollenbeck BK; Bassily N; Wei JT; Montie JE; Hayasaka S; Taylor JM; Rubin MA
    J Urol; 2000 Nov; 164(5):1583-6. PubMed ID: 11025709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations.
    Trpkov K; Grignon DJ; Bonsib SM; Amin MB; Billis A; Lopez-Beltran A; Samaratunga H; Tamboli P; Delahunt B; Egevad L; Montironi R; Srigley JR;
    Am J Surg Pathol; 2013 Oct; 37(10):1505-17. PubMed ID: 24025521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discrepancy between local and central pathological review of radical prostatectomy specimens.
    Kuroiwa K; Shiraishi T; Ogawa O; Usami M; Hirao Y; Naito S;
    J Urol; 2010 Mar; 183(3):952-7. PubMed ID: 20083260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radical prostatectomy: processing, staging, and prognosis. Parts I and II.
    Epstein JI
    Int J Surg Pathol; 2010 Jun; 18(3 Suppl):118S-123S. PubMed ID: 20484275
    [No Abstract]   [Full Text] [Related]  

  • 25. Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy.
    Khoddami SM; Shariat SF; Lotan Y; Saboorian H; McConnell JD; Sagalowsky AI; Roehrborn CG; Koeneman KS
    BJU Int; 2004 Jul; 94(1):42-6. PubMed ID: 15217428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Handling and reporting of pelvic lymphadenectomy specimens in prostate and bladder cancer: a web-based survey by the European Network of Uropathology.
    Prendeville S; Berney DM; Bubendorf L; Compérat E; Egevad L; Hes O; Kristiansen G; Oxley J; van Leenders GJLH; Varma M; van der Kwast T
    Histopathology; 2019 May; 74(6):844-852. PubMed ID: 30604878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of whole mount processing and systematic sampling of radical prostatectomy specimens: pathological outcomes and risk of biochemical recurrence.
    Salem S; Chang SS; Clark PE; Davis R; Herrell SD; Kordan Y; Wills ML; Shappell SB; Baumgartner R; Phillips S; Smith JA; Cookson MS; Barocas DA
    J Urol; 2010 Oct; 184(4):1334-40. PubMed ID: 20723932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Permanent prostate brachytherapy: pathologic implications as assessed on radical prostatectomy specimens of broadening selection criteria for monotherapy.
    Sengupta S; Davis BJ; Mynderse LA; Sebo TJ; Cheville JC; Lohse CM; Hillman DW; Haddock MG; Wilson TM
    Urology; 2006 Oct; 68(4):810-4. PubMed ID: 17070358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathologic staging of prostate carcinoma. What are the issues?
    Grignon DJ; Sakr WA
    Cancer; 1996 Jul; 78(2):337-40. PubMed ID: 8674013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy.
    Shariat SF; Khoddami SM; Saboorian H; Koeneman KS; Sagalowsky AI; Cadeddu JA; McConnell JD; Holmes MN; Roehrborn CG
    J Urol; 2004 Mar; 171(3):1122-7. PubMed ID: 14767284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the pathologist in the evaluation of radical prostatectomy specimens.
    Ekici S; Ayhan A; Erkan I; Bakkaloğlu M; Ozen H
    Scand J Urol Nephrol; 2003; 37(5):387-91. PubMed ID: 14594686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limited value of perineural invasion in radical prostatectomy specimens as a predictor of biochemical recurrence in Japanese men with clinically localized prostate cancer.
    Miyake H; Sakai I; Harada K; Eto H; Hara I
    Hinyokika Kiyo; 2005 Apr; 51(4):241-6. PubMed ID: 15912782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cancer reporting and staging: needle biopsy and radical prostatectomy specimens.
    Grignon DJ
    Mod Pathol; 2018 Jan; 31(S1):S96-109. PubMed ID: 29297497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer.
    Wieder JA; Soloway MS
    J Urol; 1998 Aug; 160(2):299-315. PubMed ID: 9679867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of tertiary Gleason pattern 5 in Gleason score 7 radical prostatectomy specimens.
    Whittemore DE; Hick EJ; Carter MR; Moul JW; Miranda-Sousa AJ; Sexton WJ
    J Urol; 2008 Feb; 179(2):516-22; discussion 522. PubMed ID: 18076949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Morphologic results of 106 consecutive radical prostatectomy specimen of patients with clinical stage B1-B3 (T2a-c) and histologically negative lymph nodes in the fossa obturatoria].
    Hübner D; Henke RP; Hammerer P; Huland H
    Urologe A; 1994 Nov; 33(6):497-504. PubMed ID: 7817447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recurrence following radical surgery for prostatic cancer. Analysis of clinical, biological and anatomo-pathological prognostic factors].
    Feyaerts A; Delrée A; Lorge F; Opsomer RJ; Wese FX; Van Cangh PJ; Draguet AP; Cosyns JP
    Acta Urol Belg; 1997 Mar; 65(1):11-8. PubMed ID: 9245198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing prostate specimen handling for diagnosis and prognosis.
    Bostwick DG; Day CE; Meiers I
    Methods Mol Biol; 2014; 1180():337-52. PubMed ID: 25015158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy.
    Sankin A; Tareen B; Lepor H
    Prostate Cancer Prostatic Dis; 2009; 12(2):204-8. PubMed ID: 19238170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.